Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer
Pharma Tech
Apnimed scouts $160m IPO to back late-stage sleep apnoea pill development
Apnimed will use the IPO funds to progress lead candidate oxnimbi, which could become the first pill to break onto the OSA market.
Read Full Article
Pharma Tech
BioMarin and n-Lorem partner on early research for ReNU syndrome therapy
BioMarin Pharmaceutical and n-Lorem Foundation have entered a collaboration and licence agreement to develop an investigational ASO therapy for ReNU syndrome.
Read Full Article
Express Pharma
Panel Discussion: India Pharma 2030 Can North India become the next global manufacturing powerhouse
Chandigarh Pharma Summit 2026 | 16th July 2026 The post Panel Discussion: India Pharma 2030 Can North India become the next global manufacturing powerhouse appeared first on Express Pharma.
Read Full Article
Express Pharma
Mr Shivaji Chakraborty, Head – Packaging Development, Fresenius Kabi Oncology
Chandigarh Pharma Summit 2026 | 16th July 2026 The post Mr Shivaji Chakraborty, Head – Packaging Development, Fresenius Kabi Oncology appeared first on Express Pharma.
Read Full Article
Express Pharma
Mr Abhinav Vikash, Head Engineering, Sun Pharmaceutical Industries
Chandigarh Pharma Summit 2026 | 16th July 2026 The post Mr Abhinav Vikash, Head Engineering, Sun Pharmaceutical Industries appeared first on Express Pharma.
Read Full Article
Sponsored content
Featured promotional
News
Latest stories
PharmaShots
Jul 28, 2026, 12:30 PM
Dyne Therapeutics Reports IND Clearance to Initiate P-I Trial of DYNE-302 for FSHD
Shots: Ref: Globenewswire | Image: Dyne Therapeutics | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Dyne Therapeutics Reports IND Clearance to Initiate P-I Trial of DYNE-302 for FSHD appeared first on PharmaShots.
ET Pharma
Jul 28, 2026, 11:43 AM
GSK launches $2.5 billion savings drive to boost drug pipeline
"To fund investment in the late-stage portfolio and R&D, we are starting a 3-year cost-savings programme to simplify the organisation and to reallocate capital and resources," Miels said in a statement.
PharmaShots
Jul 28, 2026, 11:30 AM
Hansoh Pharma Reports P-III (ARTEMIS-011) Trial Data on Ris-Rez for Osteosarcoma
Shots: Ref: Hansoh | Image: Hansoh | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Hansoh Pharma Reports P-III (ARTEMIS-011) Trial Data on Ris-Rez for Osteosarcoma appeared first on PharmaShots.
ET Pharma
Jul 28, 2026, 11:29 AM
Sun Pharma partner Philogen resubmits Nidlegy application in Europe
The revised application includes additional Chemistry, Manufacturing and Controls (CMC) information intended to address the outstanding questions raised during the previous procedure.
PharmaShots
Jul 28, 2026, 10:30 AM
CSL Reports P-IIIb Trial Data on Andembry for HAE
Shots: Ref: PRnewswire | Image: CSL | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post CSL Reports P-IIIb Trial Data on Andembry for HAE appeared first on PharmaShots.
Pharma Tech
Jul 28, 2026, 10:26 AM
Apnimed scouts $160m IPO to back late-stage sleep apnoea pill development
Apnimed will use the IPO funds to progress lead candidate oxnimbi, which could become the first pill to break onto the OSA market.
News
Latest industry coverage
Google News
Jul 28, 2026, 6:32 PM
Glenmark Pharmaceuticals Inc., USA launches Sugammadex Injection, 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials - PR Newswire
Glenmark Pharmaceuticals Inc., USA launches Sugammadex Injection, 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials PR Newswire
Google News
Jul 28, 2026, 6:14 PM
Novo Nordisk must face US shareholder lawsuit over CagriSema clinical trial - Reuters
Novo Nordisk must face US shareholder lawsuit over CagriSema clinical trial Reuters
Google News
Jul 28, 2026, 6:01 PM
The reform booster shot that transformed India into pharmacy of the world | Economy & Policy News - Business Standard
The reform booster shot that transformed India into pharmacy of the world | Economy & Policy News Business Standard
Google News
Jul 28, 2026, 5:47 PM
Breakingviews - Big Pharma gets a lesson in trusting the science - Reuters
Breakingviews - Big Pharma gets a lesson in trusting the science Reuters
Google News
Jul 28, 2026, 5:47 PM
GSK to cut jobs amid £1.9bn cost-cutting plan and bid for faster drug development - The Guardian
GSK to cut jobs amid £1.9bn cost-cutting plan and bid for faster drug development The Guardian
Google News
Jul 28, 2026, 5:43 PM
Should Anticipated Earnings Beat and Employer Award Recognition Require Action From Jazz Pharmaceuticals (JAZZ) Investors? - simplywall.st
Should Anticipated Earnings Beat and Employer Award Recognition Require Action From Jazz Pharmaceuticals (JAZZ) Investors? simplywall.st
Google News
Jul 28, 2026, 5:36 PM
GSK heads to Cambridge with long-awaited positive vibes | Nils Pratley - The Guardian
GSK heads to Cambridge with long-awaited positive vibes | Nils Pratley The Guardian
Google News
Jul 28, 2026, 5:33 PM
Blackburn goes after dark-money group calling her ‘queen pharma mama’ - Tennessee Lookout
Blackburn goes after dark-money group calling her ‘queen pharma mama’ Tennessee Lookout
Google News
Jul 28, 2026, 5:02 PM
Why Spray Drying Is Gaining Attention as a Biologics Lifecycle Management Strategy - Contract Pharma
Why Spray Drying Is Gaining Attention as a Biologics Lifecycle Management Strategy Contract Pharma
Sponsored placement
Featured promotions
Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer